Help
BMI
journal
New interview with Dr Paul Lampe now available
Journal newsletter sent to subscribers in week 37, 2009. Follow link to see newsletter summary. Register to receive newsletters.
Read an interview with editorial board member Dr Lawrence Cheskin
Read an interview with editorial board member Dr Barbara Guinn
Journal newsletter sent to subscribers in week 36, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 33, 2009. Register to receive future newsletters.
Biomarker Insights is now indexed by Pubmed
Journal newsletter sent to subscribers in week 31, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 30, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 29, 2009. Register to receive future newsletters.
Read an interview with Associate Editor Dr Karen Pulford
Read the Editor in Chief's call for papers
Journal newsletter sent to subscribers in week 26, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 23, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 20, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 19, 2009. Register to receive future newsletters.
Follow this journal on Twitter
Journal newsletter sent to subscribers in week 13, 2009. Register to receive future newsletters.
The journal has been accepted for indexing in EBSCO Academic Search Complete.
New call for papers sent to newsletter subscribers in week 10 2009. Readers who wish to be elligible to receive CFPs should subscribe to the newsletter.
Journal newsletter sent to subscribers in week 8, 2009. Register to receive future newsletters.
Journal newsletter sent to subscribers in week 7, 2009. Register to receive future newsletters.
Peer reviewers are sought. Click here to apply or to update your details.
Aims and scope:
Biomarker Insights is a peer-reviewed, open-access research journal where those engaged in biomarker research can turn for rapid communication of the latest advances in the application of biomarkers toward the discovery of new knowledge, and toward the clinical translation of that knowledge to increase the efficacy of practicing clinicians. Papers submitted for review in Biomarker Insights should focus on the following areas:
Editorial standards and procedures:
Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers. Reviewers are required to provide fair, balanced and constructive reports.
Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair. Appeals are considered by the Editor in Chief or Associate Editor.
Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.
Indexing:
This journal is indexed by the following services:
SPARC Europe Seal award winner:
This journal has been awarded a SPARC Europe Seal. The Seal is an initiative of SPARC Europe (Scholarly Publishing and Academic Resources Coalition) and the Directory of Open Access Journals (DOAJ) which is awarded to journals applying a Creative Commons CC-BY copyright license and that make journal metadata accessible to DOAJ.
Amongst other important services DOAJ makes metadata OAI-compliant. This in turn enhances the visibility of papers and allows OAI-harvesters to include the details of journal articles in their services. We encourage readers to make use of this valuable resource. The DOAJ search page is available here.
National Institutes of Health Public Access Policy compliant:
As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.
If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf.
Call for papers:
Read the Editor in Chief's latest call for papers here.All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy. Copyright in published articles remains with the author(s). Authors are continually informed of the progress of their paper and our staff are friendly and responsive.
One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."
Criteria for publication:
Publication is dependent on peer reviewers' judgement of papers. Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility.
Previous work in the field must be acknowledged and papers should read without unreasonable difficulty. Papers should fit comfortably within the scope of the journal.
Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research. They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible.
More information on the role of peer reviewers is available on the information for reviewers page. Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.
Articles submitted to other journals:
We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication.
Services for authors:
Prior to peer review of your paper we can:
After peer review of your paper we can:
What other authors have said:
Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards. Here's what some recent authors have said about us:
"Within a couple of days the reviewers had been procured and the manuscript was out."
"The communication between your staff and me has been terrific. Whenever progress is made with the manuscript, I receive notice. Quite honestly, I've never had such complete communication with a journal."
"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."
Article processing fees:
All submissions to this journal are subject to an article processing fee if they are accepted for publication. Article processing fees are used to fund the processing of your paper and development of the journal. Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor. There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.
Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations. Authors must be able to verifiably demonstrate their suitability for a discount or waiver. Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion. Waivers and discounts must be applied for prior to submission. Neither are available after submission.
Register as a peer reviewer:
Do you wish to register as a peer reviewer? Or are you already a registered peer reviewer but you need to update your contact details? To register or update your details visit the peer reviewer registration form.
Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.
Stephen F Kingsmore is President and CEO of the National Center for Genome Resources, Santa Fe, NM. NCGR is an independent, non-profit, bioinformatics research institute, focused on improving human health and nutrition by translating bioscience research with computing and math. Dr Kingsmore's current research is focused on the development of biomarkers to predict outcomes in infectious diseases. Previously, Dr. Kingsmore was in senior management positions in two biotechnology companies developing novel technologies for drug discovery and development: From 1999-2004, he was Chief Operating Officer of Molecular Staging Inc., New Haven, CT and Vice President of Research of CuraGen Corporation, New Haven, CT.
Before that, Dr Kingsmore was an Assistant Professor at the University of Florida in Gainesville, where he positionally cloned 5 disease genes. He has published over 75 peer-reviewed research papers on clinical biomarker development, and disease gene identification. Dr. Kingsmore received a B.S. in medical microbiology from the Queen's University of Belfast with first class honors in 1982 and graduated in medicine (M.B., Ch.B., B.A.O.) from the same institution in 1985. He completed internship and residency in Internal Medicine, and a fellowship in Rheumatology, at Duke University Medical Center, Durham, NC, USA.
>> Dr Kingsmore's latest call for papers
Associate Editor:
Karen Pulford, MA., PhD., FRCPath.,
University Reader in Immunodiagnostics and Director of the Leukaemia Research Lymphoma Antigens Group
Since 1981 Dr Pulford has worked at the University of Oxford on monoclonal antibody production, their characterisation and use specifically in the field of haematological malignancies. Many of my antibodies have been invaluable for improving the diagnosis of lymphoma and identifying high-risk patients.
During this time she also became interested in the immune response of patients to their tumour antigens. Part of her current work includes the development of a lymphoma vaccine. She is also a member of the newly established EuroMabNet - an international group working with and advising on the use of monoclonal antibodies.
Editorial Board:
Jeffrey L Anderson, MD
Professor of Internal Medicine, University of Utah School of Medicine; Associate Chief of Cardiology, Co-Director of Cardiovascular Research, LDS Hospital; Salt Lake City, UT, USA
Leigh Anderson, PhD
Chief Executive Officer, Plasma Proteome Institute, Washington, DC, USA
Peter E Barker, PhD
Biologist & Project Leader, NIST Biomarkers Validation and Reference Laboratory National Institute of Standards and Technology (NIST), Gaithersburg, MD, USA
Douglas Charles Bauer, MD
Professor of Medicine, Epidemiology, and Biostatistics. Director of Research Programs UCSF Division of General Internal Medicine University of California, San Francisco, CA, USA
Carsten Bergmann, MD, Priv.-Doz.
Consultant, Department of Human Genetics, RWTH Aachen University, Aachen, Germany
Kristin J Bergsland, PhD
Director of Research & Development, Litholink Corporation, Chicago, IL, USA
Roberd M Bostick, MD, MPH
Professor of Epidemiology and of (Joint) Hematology and Oncology, Emory University, Atlanta, GA, USA
Lawrence J Cheskin, MD, FACP
Director, Johns Hopkins Weight Management Centre, Associate Professor, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
David Chia, PhD
Professor of Pathology and Laboratory Medicine, University of California, Los Angeles, CA, USA
William C S Cho, PhD
Scientific Officer (Oncology), Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China.
Svein G Dahl, PhD
Professor of Pharmacology, University of Tromsø, Tromsø, Norway
Peter Dedon, MD, PhD
Professor of Toxicology and Biological Engineering; Associate Director, Biological Engineering Division; Deputy Director, MIT Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA
Jochen Greiner, MD
Professor, Department of Hematology and Oncology, Third Department of Medicine, University of Ulm, Ulm, Germany
Barbara A Guinn, PhD
Principal Investigator, Department of Haematological Medicine, King's College London School of Medicine, London, UK
Brian B Haab, PhD
Scientific Investigator, Van Andel Research Institute, Grand Rapids, MI, USA
Ian Humphery-Smith, PhD
Chief Executive Officer, Biosystems Informatics Institute, Newcastle upon Tyne, UK
JA Jeddeloh, PhD
Director, Biomarker Discovery and Detection, Orion Genomics, St Louis, MO, USA
Peter A Kanetsky, PhD, MPH
Assistant Professor, Department of Biostatistics & Epidemiology, Center for Clinical Epidemiology & Biostatistics, Philadelphia, PA, USA
Urban A Kiernan, PhD
Senior Research Scientist, Intrinsic Bioprobes Inc, Tempe, AZ, USA
Virginia Byers Kraus, MD, PhD
Associate Professor of Medicine, Division of Rheumatology, Duke University Medical Center, Durham, NC, USA
Paul Lampe, PhD
Full Member, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Steven R Levine, MD
Professor of Neurology, The Mount Sinai School of Medicine, New York, NY, USA
Zibo Li, PhD
Assistant Professor, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Mark W Lingen, DDS, PhD
Associate Professor of Pathology, Medicine and Radiation & Cellular Oncology, The University of Chicago, Chicago, IL, USA
Gregory M Loewen, DO, FCCP
Associate Professor of Clinical Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
Kun Ping Lu, MD, PhD
Associate Professor of Medicine, Cancer Biology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Bashir Abdulgader Lwaleed, MD
Urology, Southampton University Hospitals NHS Trust, Southampton, Hampshire, United Kingdom
Patrick McConville, PhD
Director, Imaging Services, Discovery and Imaging Services, Charles River Laboratories, Ann Arbor, MI, USA
Elizabeth J Murphy, MD, DPhil
Chief, Division of Endocrinology and Metabolism, San Francisco General Hospital, University of California, San Francisco, CA, USA
Steven Myers, PhD
Associate Professor, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA
Andrea Nicolini, MD
Clinical Researcher, Department of Internal Medicine, University of Pisa, Pisa, Italy
Dhavalkumar D Patel, MD, PhD
Joseph P Archie Jr Eminent Professor of Medicine, University of North Carolina, Chapel Hill, NC, USA; and Head, Fully Integrated Program in Rheumatoid Arthritis, Novartis Institutes of Biomedical Research, Basel, Switzerland
Wael El-Rifai, MD, PhD
Professor, Surgery, Medicine & Cancer. Biology Director, Surgical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA
David L Rimm, MD, PhD
Associate Professor of Pathology. Director, YCC Tissue Microarray Facility. Cytopathology Fellowship Program Director, Yale University School of Medicine, New Haven, CT, USA
Paul Rolan, MBBS, MD, FRACP, FFPM
Professor of Clinical Pharmacology, University of Adelaide, Adelaide, SA, Australia
Edward R Sauter, MD, PhD
Professor; Vice Chair for Research, Department of Surgery, University of Missouri-Columbia, Columbia, MO, USA
O John Semmes, PhD
Scientific Director, Virginia Prostate Center. Director, Center for Biomedical Proteomics.
Professor, Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA, USA
Dennis Sgroi, MD
Molecular Pathology Research Unit, Charlestown, MA, USA
David W Speicher, PhD
Professor and Chair, Systems Biology Division, Director, Proteomics Laboratory, The Wistar Institute, Philadelphia, PA, USA
Pei Tang, PhD
Associate Professor, Departments of Anesthesiology, Pharmacology, & Computational Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Douglas D Taylor, MD, PhD
Professor of Obstetrics and Gynecology, University of Louiseville School of Medicine, Louisville, KY, USA
Visith Thongboonkerd, PhD
Medical Proteomics Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Gregory E Tullis, PhD
Associate Professor, Department of Ophthamology, Boston University, Boston, MA, USA
Scott M Turner, PhD
Vice President, Operations, KineMed Inc, Emeryville, CA, USA
Timothy D Veenstra, PhD
Laboratory of Proteomics and Analytical Technologies SAIC-Frederick, Inc, National Cancer Institute at Frederick, Frederick, MD, USA
Timothy S Vincent, PhD
Associate Director of Proteomics, West Virginia University, Morgantown, WV, USA
Lorraine B Ware, MD
Assistant Professor of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
Marc A. Williams Ph.D.
Biologist, US Environmental Protection Agency, Research Triangle Park, N.C., USA
Richard C Zangar, PhD
Senior Research Scientist, Pacific Northwest National Laboratory, Richland, WA, USA
David A Zisman, MD, PhD
Assistant Professor of Medicine, Medical Director, Interstitial Lung Disease Program, University of California, Los Angeles, CA, USA
Copyright © 2011 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)
